Blog

Nelson Advisors has been referenced by Cyberside Chats in their 'Better Than Google, Still Risky: The OpenEvidence Story'.Source: <a href="https://www.chatcyberside.com/e/better-than-google-still-risky-the-openevidence-story/" data-mce-href="https://www.chatcyberside.com/e/better-than-google-still-risky-the-openevidence-story/">https://www.chatcyberside.com/e/better-than-google-still-risky-the-openevidence-story/</a>Better Than Google, Still Risky: The OpenEvidence Story'65% of US doctors are using an AI tool their hospital never approved — on personal phones, under click-through contracts. Sherri and Matt unpack what every CISO and IT leader should learn from it about shadow AI, "free" professional tools, and the contracts nobody's reading.The tool is OpenEvidence — 27 million clinical queries in April 2026 alone, 60% of them shaping actual treatment decisions. Doctors love it because the alternative was Googling patient symptoms on a personal browser. Their hospitals mostly don't know it's happening, and the vendor's click-through Business Associate Agreement authorizes them to use that data to train their models forever.Healthcare is the example. The same pattern is showing up in legal, financial services, engineering, and HR right now — different tool, same structural risk. Tune in for five concrete takeaways security and IT leaders can use this week.Key Takeaways:Inventory shadow AI. Ask your staff what AI tools they use to do their jobs, not whether they're using unauthorized tools. The real number is likely 2–5x what you'll find. Read the actual contract before letting any AI tool touch sensitive data. Find the training-data clause, the termination clause, the audit rights, and who the "Customer" really is. Click-through BAAs don't protect the employer. Treat every AI prompt as a disclosure. Removing names doesn't make data safe. Combinations of attributes, dates, locations, roles, rare events, can re-identify people even without a name attached. Take a position on shadow AI and communicate it. Decide which tools your organization sanctions, which it blocks, and which fall in between. Silence is implicit endorsement. Push back on every "free" professional AI tool. Ask who's paying and what they're buying. If it's not you, the product is your professionals' decisions.Resources:https://www.nbcnews.com/tech/tech-news/openevidence-ai-doctor-medical-physician-login-app-what-npi-uptodate-rcna341064 <a href="https://www.healthcare.digital/single-post/clinical-intelligence-a-strategic-analysis-of-openevidence-and-the-multi-agent-medical-ai-ecosystem" data-mce-href="https://www.healthcare.digital/single-post/clinical-intelligence-a-strategic-analysis-of-openevidence-and-the-multi-agent-medical-ai-ecosystem">https://www.healthcare.digital/single-post/clinical-intelligence-a-strategic-analysis-of-openevidence-and-the-multi-agent-medical-ai-ecosystem</a> https://www.ama-assn.org/system/files/physician-ai-sentiment-report.pdf

Nelson Advisors referenced in the 'Better Than Google, Still Risky: The OpenEvidence Story'

Nelson Advisors has been invited back to the Global Health Exhibition 2026 to take part in the ICapital Xchange Programme.Global Health Exhibition 2026Global Health Exhibition is the meeting point for the world’s healthcare innovators.Here, global leaders, decision-makers, and solution providers come together to accelerate digital transformation, advance new models of care, and build a more integrated, tech-driven healthcare ecosystem.From AI in clinical practice and digital health to workforce evolution and breakthrough medical technologies, Global Health Exhibition showcases the trends and partnerships shaping the next era of global health.Capital Xchange Programme 2026The Capital Xchange Programme is the evolution of the Global Health Exhibition Investor Programme, designed as a curated platform for global investors, innovators and government stakeholders driving healthcare transformation.By bringing together capital providers, high-growth healthcare companies and Saudi policy leaders, the programme creates pathways for strategic investment, partnerships and market entry within one of the world’s fastest growing healthcare markets.&nbsp;Participants gain direct insight into regulatory frameworks, emerging opportunities and the priorities shaping Saudi Arabia’s Vision 2030 healthcare transformation.Source: <a href="https://www.globalhealthsaudi.com/">https://www.globalhealthsaudi.com/</a>Source: &nbsp;<a href="https://www.globalhealthsaudi.com/investors-and-startups/invest-in-health/">https://www.globalhealthsaudi.com/investors-and-startups/invest-in-health/</a>

Nelson Advisors invited back to the Global Health Exhibition 2026

European HealthTech has seen a massive surge in specialised AI deployments and notable funding rounds this week, particularly focusing on optimising operational workflows, surgical intelligence and deep-tech. medical solutions. &nbsp;&nbsp; Here are the key developments shaping the ecosystem right now. Funding &amp; Expansion Boosts Health Secures $15M Series A: The UK-based HealthTech platform closed a major round to aggressively scale its specialist healthcare infrastructure.Thena Capital Launches £45M Debut Fund: Led entirely by female general partners, the firm closed its initial fund aimed at backing up to 25 early-stage healthcare and MedTech startups, with a heavy emphasis on how AI will transform clinical pathways.OurMind Lands €2.1M: The Dutch startup raised new capital specifically to scale its AI-driven platform designed to alleviate heavy administrative workloads from burnt-out clinical staff.Surgical and Operational AI Take Center Stage The narrative this week is strongly focused on highly niche, practical artificial intelligence applications rather than broad LLMs. Uncovr Raises $7M for Surgical AI: This startup secured fresh capital to build out dedicated AI infrastructure for operating theatres. Rather than diagnosing, its models focus on clinical documentation and workflow intelligence to automate post-op paperwork for surgeons.TurnUp Tackles Practice Efficiencies: Based in Ghent, TurnUp raised €2 million for an intelligent system designed to drastically reduce "no-shows" and last-minute cancellations for dental and medical practices across Europe.Nanordica Medical Raises €1.6M: The Estonian MedTech firm took home new funding to fast-track its advanced, antibiotic-free chronic wound care treatment, targeting the massive European medical logistics market.Regulatory Alignment &amp; Scale The tail-end effects of the dual consolidation of the EU AI Act and Medical Device Regulations (MDR/IVDR) continue to dominate operational roadmaps. Medical software developers across the continent are seeing stricter enforcement regarding data quality and human oversight. Because of this, standard security frameworks like SOC 2 are rapidly transitioning from "nice to have" to a strictly non-negotiable entry requirement for any startup trying to integrate data directly into European hospital Electronic Health Records (EHRs). &gt;&gt;&gt;&gt; &nbsp;&nbsp; The European MedTech sector has experienced a highly active week, marked by major growth funding, critical legislative pushback over AI medical regulations, and a substantial shift in the UK's regulatory framework to attract global hardware innovation. Here are the biggest headlines driving the industry this week. Funding &amp; Market Growth &nbsp;&nbsp; A newly released sector report by Tech.eu highlights that capital is concentrating into larger, highly commercialised rounds, specifically in the UK (€2.5B), Switzerland (~€1.0B), and Finland (€881M). Semble Secures £30M Series C: The London-based medical tech platform closed a massive growth round led by European growth investor Revaia (with Partech and Octopus Ventures). Semble operates an open, interoperable clinical platform that connects disjointed healthcare tech systems. The capital will fund its expansion into France and larger European healthcare groups.EU Directing €11.5M to DeepTech Therapeutics: The EU Grants Funding portal highlighted a major €11.57 million allocation explicitly targeting companies scaling high-readiness (TRL 6–8) solutions in advanced therapeutics and the secondary clinical use of interoperable health data.The AI Act &amp; MDR "Parallel Regulatory" Clash &nbsp;&nbsp; A major point of friction reached a boiling point following a political agreement on the Digital Omnibus, which amends the landmark EU AI Act. The Conflict: MedTech Europe (the region's primary trade association) had heavily lobbied for AI-enabled medical technologies to be governed strictly under existing sector-specific medical rules. Instead, the final deal confirms that AI medical devices will remain subject to overlapping, parallel compliance requirements from both the AI Act and the Medical Devices Regulation (MDR).The Backlash: Industry leaders expressed deep disappointment, stating it adds "an unnecessary layer of complexity" to an already heavily strained framework. The industry is currently mobilizing to pressure the EU to simplify these overlapping rules, which the EU Parliament projects could save the industry up to €3.3 Billion annually in wiped-out administrative bloat.EMA Innovation Pilot: In a positive regulatory turn, the European Medicines Agency (EMA) launched an innovative device pilot program for Class III and implantable devices, which industry experts are praising as a precursor to a formal, US-style "breakthrough device" pathway.The UK Proposes the "International Reliance" Pathway In response to the ongoing regulatory hurdles in mainland Europe, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published its draft Medical Devices (Amendment) Regulations 2026. &nbsp;&nbsp; The Big Shift: The draft officially introduces an International Reliance Pathway. This allows medical device manufacturers who have already secured regulatory clearance in trusted global markets (like the US FDA) to bypass redundant testing and access the Great Britain market via a drastically fast-tracked, simplified review process. The "AI Literacy" Medical Liability Threat As data from the newly released Philips Future Health Index 2026 reveals that nearly two-thirds (65%) of European clinicians have ramped up their use of medical AI to save time, a hidden legal risk has emerged. &nbsp; Medical device manufacturers are facing a growing threat of liability exposure due to diluted and vague EU guidelines on clinician "AI literacy."&nbsp; Regulatory experts warned this week that because formal training requirements have been diluted in recent legislative drafts, manufacturers are increasingly at risk if a clinician incorrectly interprets an AI device's output and causes patient harm.Nelson Advisors &gt; European MedTech and HealthTech Investment Banking &nbsp; Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. <a href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis &amp; predictions @ <a href="https://www.healthcare.digital">https://www.healthcare.digital&nbsp;</a>&nbsp;Nelson Advisors publish Europe’s leading HealthTech and MedTech M&amp;A Newsletter every week, subscribe today! <a href="https://lnkd.in/e5hTp_xb">https://lnkd.in/e5hTp_xb&nbsp;</a>&nbsp; Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. <a href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>&nbsp;#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech Nelson Advisors LLP &nbsp; Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT lloyd@nelsonadvisors.co.uk paul@nelsonadvisors.co.uk Meet Nelson Advisors @ 2026 Events &nbsp; Digital Health Rewired &gt; March 2026 &gt; Birmingham, UK&nbsp; &nbsp; NHS ConfedExpo &nbsp;&gt; June 2026 &gt; Manchester, UK&nbsp; &nbsp; HLTH Europe &gt; June 2026, Amsterdam, Netherlands &nbsp;&nbsp; HIMSS AI in Healthcare &gt; July 2026, New York, USA &nbsp; Bits &amp; Pretzels &gt; September 2026, Munich, Germany &nbsp; &nbsp; World Health Summit 2026 &gt; October 2026, Berlin, Germany HealthInvestor Healthcare Summit &gt; October 2026, London, UK HLTH USA 2026 &gt; October 2026, USA &nbsp; Barclays Health Elevate &gt; October 2026, London, UK&nbsp; Web Summit 2026 &gt; November 2026, Lisbon, Portugal &nbsp; &nbsp; MEDICA 2026 &gt; November 2026, Düsseldorf, Germany &nbsp;&nbsp; Venture Capital World Summit &gt; December 2026 Toronto, Canada

This Week in European MedTech and HealthTech: 12th June 2026

Nelson Advisors is proud to support the Oxford MedTech Society x Google Gemini Clinical Hackathon on 13th June 2026 as a Silver Sponsor.Source: <a href="https://oxfordmedtechsociety.com/events_luma/" data-mce-href="https://oxfordmedtechsociety.com/events_luma/">https://oxfordmedtechsociety.com/events_luma/</a><a href="https://luma.com/qtm3we72?lm_source=embed&amp;utm_source=website" data-mce-href="https://luma.com/qtm3we72?lm_source=embed&amp;utm_source=website">https://luma.com/qtm3we72?lm_source=embed&amp;utm_source=website</a>Oxford MedTech Society x Google Gemini Clinical HackathonHealthcare is full of problems waiting to be solved.​Join us for a one-day hackathon bringing together students, clinicians, researchers, designers, engineers and innovators to prototype solutions for real healthcare challenges using Google Gemini.​Across the day, participants will form teams, identify a clinical problem, develop an AI-powered concept, and pitch their solution to a panel at the end of the event. The focus is not just on building something impressive, but on creating ideas that are clinically useful, safe, scalable and grounded in real-world healthcare needs.​No advanced coding experience is required. We are looking for people who can think critically about problems, design user-centred solutions, communicate clearly, and work well in a team. Whether you come from medicine, computer science, engineering, design, business, policy or another background, you will have something valuable to contribute.​The day will include:​An introduction to the hackathon challenge ​Guidance on using Google Gemini for clinical innovation ​Team formation and ideation ​Dedicated building and mentoring time ​Final pitches and judging ​Networking with students, clinicians and innovators interested in healthcare technology ​This is a chance to explore how generative AI can be applied responsibly to clinical problems, meet others interested in medtech, and turn an idea into a prototype in a single day.​Date: 13 June 2026 Time: 09:00–17:00 Hosted by: Oxford MedTech Society and Google Gemini

Nelson Advisors proud to support the Oxford MedTech Society x Google Gemini Clinical Hackathon on 13th June 2026

Nelson Advisors have been invited to Chair and Speak on various HealthTech panels at the Healthcare Summit 2026, scheduled for September 22nd 2026.The Healthcare Summit 2026 is a premier UK conference taking place on Tuesday, 22 September 2026, at the Business Design Centre in London. Organised by Nexus Media Group, the event serves as a central hub for market insights, thought leadership, and high-level networking, bringing together over 1,000 attendees, 60 expert speakers, and 30 exhibitors.The summit focuses heavily on the business, financial, and technological future of the sector, targeting an audience of C-suite executives, healthcare CEOs, investors, and care operators. To cater to diverse interests, the agenda features specialized content tracks, including dedicated streams for Chief Financial Officers (CFOs), Chief Technology Officers (CTOs), and dental professionals, alongside sessions covering social care, complex care, property, and health tech.Key discussions will center on the latest market trends, mergers and acquisitions (M&amp;A) insights, and data-driven forecasts. A major theme is the integration of innovative technology to solve modern healthcare challenges. Prominent industry leaders from organisations like NHS England, Spire Healthcare, and The King's Fund are slated to speak. Ultimately, the event acts as a collaborative sandbox for professionals to exchange ideas, discover investment opportunities, and build strategic connections.Source: <a href="https://healthcare-summit.co.uk/2026/2026-agenda?&amp;filters.STREAM=health-tech&amp;searchgroup=FF9589DB-agenda-2026" data-mce-href="https://healthcare-summit.co.uk/2026/2026-agenda?&amp;filters.STREAM=health-tech&amp;searchgroup=FF9589DB-agenda-2026">https://healthcare-summit.co.uk/2026/2026-agenda?&amp;filters.STREAM=health-tech&amp;searchgroup=FF9589DB-agenda-2026</a>

Nelson Advisors invited to Chair and Speak on various HealthTech panels at the Healthcare Summit 2026

The healthcare technology mergers and acquisitions landscape has transitioned into a regime of industrial maturity, moving decisively past the speculative pricing cycles of the post-pandemic era. During the height of the market peak, high-growth digital health platforms were valued primarily on projected revenue expansion, frequently disregarding long-term margin profiles or underlying product defensibility. This pricing paradigm has been replaced by a rigorous valuation discipline that penalises standalone applications while heavily rewarding integrated, operationally defensive enterprise systems. &nbsp;&nbsp; This macroeconomic correction is clearly illustrated by the overall market transaction values and volumes. In 2025, global health industries M&amp;A values rose by 46%, even as transaction volumes declined by 5%. This divergence represents a dramatic concentration of capital into high-quality, large scale assets, highlighted by 11 mega deals that closed during the year.&nbsp; &nbsp;&nbsp; Furthermore, roughly 70% of total transaction value in 2025 originated from fewer than ten large deals, showcasing a persistent capital clustering at the top end of the market. &nbsp;&nbsp; Underpinning this structural shift is the performance of the "Health Tech 2.0" cohort. This group, which includes companies like Waystar, Tempus AI, Hinge Health, Omada Health, Caris Life Sciences and HeartFlow, represents platforms that combine sustainable, high-velocity growth with clear operating leverage and robust data assets.Strategic Conclusions and Outlook &nbsp;&nbsp; The repricing of HealthTech M&amp;A has established a clear division between shallow software wrappers and defensible clinical operating systems. Standalone point solutions that increase administrative complexity face continuing valuation pressure. Conversely, integrated, EHR-native platforms that automate workflows, improve margins, and maintain strong compliance moats command significant premiums. &nbsp;&nbsp; For digital health founders, long-term value creation depends on clinical validation, regulatory readiness, and moving away from single-feature software models toward integrated enterprise solutions.&nbsp; &nbsp;&nbsp; For private equity and strategic buyers, success in this market requires executing deep, clinical due diligence, structuring performance-linked earn outs, and prioritising platforms that sit directly within core clinical and financial workflows.Read the full article here <a href="https://www.healthcare.digital/single-post/wrapper-or-moat-how-ai-is-re-pricing-healthtech-m-a">https://www.healthcare.digital/single-post/wrapper-or-moat-how-ai-is-re-pricing-healthtech-m-a</a>

Nelson Advisors

Blog

Nelson Advisors referenced in the 'Better Than Google, St...

Nelson Advisors invited back to the Global Health Exhibit...

This Week in European MedTech and HealthTech: 12th June 2026

Nelson Advisors proud to support the Oxford MedTech Socie...

Nelson Advisors invited to Chair and Speak on various Hea...

Wrapper or Moat? The Macroeconomic Re-Correction and the ...